Research
Metabolic adaptation
Endpoints predominantly independent of weight loss include hemoglobin A1c and fasting plasma glucose in individuals with and without T2DM.
Liraglutide may improve glycemic control independently of weight loss.
StrongSupportsmedium confidence
Endpoints predominantly independent of weight loss included the glycemic endpoints hemoglobin A1c and fasting plasma glucose in individuals with and without T2DM.
Why this rating
Based on data from multiple trials assessing various endpoints.
Source
Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects
Harold Bays et al. · Current Medical Research and Opinion · 2016
rct · n=4725Cited 48×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →